Receptor tyrosine kinases and downstream pathways as druggable targets for cancer treatment: the current arsenal of inhibitors. [electronic resource]
Producer: 20190116Description: 55 p. digitalISSN:- 1476-4598
- Animals
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Biomarkers, Tumor
- Clinical Trials as Topic
- Drug Discovery
- Drug Resistance, Neoplasm
- Humans
- Molecular Targeted Therapy
- Mutation
- Neoplasms -- drug therapy
- Protein Binding
- Protein Kinase Inhibitors -- pharmacology
- Receptor Protein-Tyrosine Kinases -- antagonists & inhibitors
- Signal Transduction -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.